Geron Corporation: Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
Innovation Passport Designation Awarded to Imetelstat for the Treatment of Lower Risk Myelodysplastic Syndromes Pathway Intended to Expedite Regulatory Review Process Geron Corporation (Nasdaq:
Source: finanznachrichten.de